Target intelligence / Profile preview

NIFK pseudogene 2 (NIFKP2)

Target
NIFKP2
Molecular classification
Pseudogene, Noncoding RNA locus (potentially transcribed), Other (if specifically mentioned in genomic databases)
01

Overview

NIFK pseudogene 2 is a genomic locus classified as a pseudogene, believed to be derived from NIFK, which encodes a nucleolar protein that interacts with MKI67 (a marker of cell proliferation). Pseudogenes like NIFKP2 typically do not generate functional proteins due to the accumulation of mutations such as frame shifts or premature stop codons. Recent research suggests that some pseudogenes can be transcriptionally active, influencing gene regulation by acting as RNA decoys for microRNAs or producing small interfering RNAs, thereby modulating their parent gene's expression or participating in complex regulatory networks. However, for NIFK pseudogene 2 specifically, no evidence has been published establishing direct biological function or disease involvement—its status remains a noncoding, nonfunctional gene without known clinical or therapeutic relevance.

Other names
NIFKP2MKI67IPP2MKI67 (FHA domain) interacting nucleolar phosphoprotein pseudogene 2nucleolar protein interacting with the FHA domain of MKI67 pseudogene 2
02

Biological functions

Regulation of gene expression (as observed for other pseudogenes)Possible microRNA decoy role or siRNA source (general pseudogene function, but not specifically demonstrated for NIFKP2)Other (potential regulatory roles, not clearly established for NIFKP2)
03

Disease associations

OtherPotential involvement in gene regulation networks (general for pseudogenes; direct disease link not established for NIFKP2)

Beyond the preview

Go deeper on NIFK pseudogene 2 (NIFKP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NIFK pseudogene 2 (NIFKP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call